Antinociceptive activity of sildenafil and adrenergic agents in the writhing test in mice

Pharmacological Reports

Volumn 60, Issue 3, 2008, Pages 339-344

  Bezerra, Mirna M ^a   Lima, Vilma ^a   Girão, Virgínia C C ^b   Teixeira, Rafael C ^a   Graça, José R V ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b STATE UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Acetic acid; Antinociception; Mice; Pain; Sildenafil

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ATENOLOL; CLONIDINE; INDOMETACIN; PRAZOSIN; PROPRANOLOL; SILDENAFIL;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; LOW DRUG DOSE; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN; WRITHING TEST;

EID: 49349118120     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Buerkle H, Schapsmeier M, Bantel C, Marcus MA, Wusten R, Van Aken H: Thermal and mechanical antinociceptive action of spinal vs peripherally administered clonidine in the rat inflamed knee joint model. Br J Anaesth, 1999, 83, 436-441.
2. Collier HO, Dinneen LC, Johnson CA, Scheider C: The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother, 1968, 32, 295-310.
3. Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH: Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol, 1991, 104, 765-767.
4. Cunha FQ, Teixeira MM, Ferreira SH: Pharmacological modulation of secondary mediator systems cyclic AMP and cyclic GMP on inflammatory hyperalgesia. Br J Pharmacol, 1999, 127, 671-678.
5. de Rosalmeida MC, Saraiva LD, da Graga JR, Ivo BB, da Nobrega MV, Gondim FA, Rola FH, dos Santos AA: Sildenafil, a phosphodiesterase-5 inhibitor, delays gastric emptying and gastrointestinal transit of liquid in awake rats. Dig Dis Sci 2003, 48, 2064-2068.
6. Eisenach JC, DuPen S, Dubois M, Miguel R, Allin D: Epidural clonidine analgesia for intractable cancer pain - The Epidural Clonidine Study Group. Pain, 1995, 61, 391-399.
7. 2+ dependent process. Prostaglandins, 1979, 18, 179-190.
8. αS protein and reduce the transient outward K+ current via a cAMP/ PKA-mediated pathway in the rat heart. Am J Physiol Cell Physiol, 2005, 288, C577-C585.
9. Gibson A: Phosphodiesterase 5 inhibitors and nitrergic transmission - from zaprinast to sildenafil. Eur J Pharmacol, 2001, 411, 1-10.
10. Gondim FA, Oliveira GR, Graca JR, Gondim RB, Alencar HM, Dantas RP, Santos AA, Rola FH: Neural mechanisms involved in the delay of gastric emptying of liquid elicited by acute blood volume expansion in awake rats. Neurogastroenterol Motil, 1999, 11, 93-99.
11. 1A-adrenoceptors to pain induced by formalin or by α-methyl-5-hydroxytryptamine plus noradrenaline. Eur J Pharmacol, 1996, 301, 41-48.
12. Jain NK, Patil CS, Singh A, Kulkarni SK: Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res, 2001, 909, 170-178.
13. Krenzelok EP: Sildenafil - clinical toxicology profile. J Toxicol Clin Toxicol, 2000, 38, 645-651.
14. Kress M, Rodl J, Reeh PW: Stable analogues of cyclic AMP but not cyclic GMP sensitize unmyelinated primary afferents in rat skin to heat stimulation but not to inflammatory mediators, in vitro. Neuroscience, 1996, 74, 609-617.
15. Kuraishi Y, Hirota N, Sato Y, Kaneko S, Satoh M, Takagi H: Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn. Brain Res, 1985, 359, 177-182.
16. Lima V, Silva CB, Mafezoli J, Bezerra MM, Moraes MO, Mourao GS, Silva JN, Oliveira MC: Antinociceptive activity of the pyranocoumarin seselin in mice. Fitoterapia, 2006, 77, 574-578.
17. Lowe FC: Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms. Clin Ther, 2004, 26, 1701-1713.
18. Mico JA, Gibert-Rahola J, Casas J, Rojas O, Serrano MI, Serrano JS: Implication of β1 - and β2-adrenergic receptors in the antinociccptive effect of tricyclic antidepressants. Eur Neuropsychopharmacol, 1997, 7, 139-145.
19. Mixcoatl-Zecuatl T, Aguirre-Banuelos P, Granados-Soto V: Sildenafil produces antinociception and increases morphine antinociception in the formalin test. Eur J Pharmacol, 2000, 400, 81-87.
20. Nader ND, Ignatowski TA, Kurek CJ, Knight PR, Spengler RN: Clonidine suppresses plasma and cerebro-spinal fluid concentrations of TNF-α during the perioperative period. Anesth Analg, 2001, 93, 363-369.
21. 2-adrenoceptors. Eur J Pharmacol, 2000, 400, 199-203.
22. Patil CS, Singh VP, Kulkarni SK: Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats. Pharmacol Rep, 2006, 58, 373-380.
23. Pyne NJ, Arshavsky V, Lochhead A: cGMP signal termination. Biochem Soc Trans, 1996, 24, 1019-1022.
24. + channel pathway. Proc Natl Acad Sci USA, 2004, 101, 3680-3685.
25. 1 imidazoline/ α2-adrenergic receptor agonist moxonidine in comparison with clonidine in the formalin test in rats. Pain, 2000, 85, 161-167.
26. 2 binding sites. Eur J Pharmacol, 2004, 501, 95-101.
27. Safieh-Garabedian B, Poole S, Haddad JJ, Massaad CA, Jabbur SJ, Saade NE: The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation. Neuropharmacology, 2002, 42, 864-872.
28. Smith R: Viagra and rationing. Let the sunlight in, let the people speak. BMJ, 1998, 317, 760-761.
29. Tonussi CR, Ferreira SH: Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. Eur J Pharmacol, 1994, 251, 173-179.
30. Uthayathas S, Karuppagounder SS, Thrash BM, Parameshwaran K, Suppiramaniam V, Dhanasekaran: Versatile effects of sildenafil: recent pharmacological applications. Pharmacol Rep, 2007, 59, 150-163.
31. Zarrindast MR, Ahmadi R, Oryan S, Parivar K, Haeri-Rohani A: Effects of α-adrenoceptor agonists and antagonists on histamine-induced impairment of memory retention of passive avoidance learning in rats. Eur J Pharmacol, 2002, 454, 193-198.